Surface-modified extracellular vesicles take their chance in the big PCSK9 inhibitors' race. [PDF]
Mol TherBen-Aicha S, Emanueli C.
europepmc +1 more source
Optimizing ibrutinib bioavailability: Formulation and assessment of hydroxypropyl-β-cyclodextrin-based nanosponge delivery systems. [PDF]
Curr Res Pharmacol Drug DiscovSampathi S +6 more
europepmc +1 more source
Atomistic Structure Investigation of Eu-Doped ZnO Nanosponges. [PDF]
Inorg ChemFeng S +4 more
europepmc +1 more source
Controlled Release Technologies for Diltiazem Hydrochloride: A Comprehensive Review of Solid Dosage Innovations. [PDF]
PharmaceuticsTroches-Mafla E, Salamanca CH, Ciro Y.
europepmc +1 more source
Exploitation of cholesterol-dependent cytolysins for targeted biosensing and therapeutic systems. [PDF]
Drug Deliv Transl ResAbanum HO, Watt E, Ho EA.
europepmc +1 more source
PEGylated PLGA Nanoformulations For Effective Immunomodulatory Actors In Non-Small Cell Lung Cancer. [PDF]
Int J NanomedicineHuang M, Zhang J, Hao Z, Wang Q, Liu W.
europepmc +1 more source
Fabrication, characterization, and docking studies of furosemide-loaded nanosponges using the emulsion solvent diffusion method. [PDF]
Nanomedicine (Lond)Liaqat R +7 more
europepmc +1 more source
Cytokine storm in acute respiratory distress syndrome. [PDF]
J Intensive MedMerola R +3 more
europepmc +1 more source
Advances in phytochemical-derived nanotherapeutics for multimodal eradication of multidrug-resistant <i>Staphylococcus aureus</i>. [PDF]
Front PharmacolGupta N +9 more
europepmc +1 more source
Efficient Delivery of CRISPR-Cas9 RNP Complexes with Cyclodextrin-Based Nanosponges for Enhanced Genome Editing: TILD-CRISPR Integration. [PDF]
Int J Mol SciAmiri S +9 more
europepmc +1 more source